We previously posted about the lawsuit against Philips regarding its Respironics CPAP machines here and here. Now in a landmark agreement, the Dutch manufacturer has reached a $1.1 billion settlement in the United States to address personal injury claims related to the recall. The deal includes provisions for personal injury claims and medical monitoring, and Philips has agreed to pay an additional €540 million to cover recall-related claims from insurers.
As is typical with these sorts of settlements, Philips does not admit any fault or liability in the matter. Instead, the company maintains that it has taken steps to address the issue and ensure patient safety.
The repercussions have been extensive. Aside from the lawsuit and associated product recall, it has also resulted in significant financial losses for the company. Philips reported a loss of €463 million in 2023 and an additional loss of €824 million in the first quarter of 2024.
While this is probably the biggest instance of CPAP failure in recent years, there are plenty of other issues with using the device to treat sleep apnea. All this helps explain why Dr. Krish deliberately avoids prescribing the CPAP and advocates the use of oral appliance therapy.
If you’re looking for a CPAP-free alternative to treating your sleep apnea, contact us today – we would love to help.
Sources:
